Innovation has and always will be a decisive factor when it comes to determining the success and survival of medical device companies.
But, although innovation accelerates, the cost and complexity of bringing a new device to market remain daunting.
Start-ups and established players alike face the same issue: how to move a concept from the lab bench to the patient’s bedside reliably, safely and at scale?
Denver Rich, Executive Director at PolarSeal, reports.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.